In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editor Dr. Catherine Frenette has assembled expert authors to provide current updates on Hepatocellular Carcinoma (HCC). This issue asks important questions and provides answers and current thoughts on the staging and treatment of HCC. Clinical review articles are specifically dedicated to the following topics: The Changing Global Epidemiology of Hepatocellular Carcinoma; Prevention Strategies for HCC; Biomarkers or Biopsy for Diagnosis of HCC; Screening and Surveillance Strategies to Improve the Chance of Success; Imaging Diagnosis of HCC; Surgical Resection: Old dog--Any new tricks; Hepatocellular Carcinoma and Liver Transplant: How Will Organ Allocation Changes Affect the HCC Patient Within Transplant Criteria; Downstaging to Liver Transplant: Success Involves Choosing the Right Patient; Locoregional Therapies for Hepatocellular Carcinoma: What has Changed in the Past Ten Years; External Beam Radiotherapy: Is There a Place for This in HCC Treatment; Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma; Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future; Management of Side Effects of Systemic Therapies for HCC: Guide for the Hepatologist; and Why a Multi-disciplinary Tumor Board is Critical for Success with Hepatocellular Carcinoma. Readers will come away with the information they need to improve patient outcomes in the patient with HCC.
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI).
Table 2 Recommended treatment of hepatitis C virus–uninfected recipients of livers from hepatitis C virus–viremic donors Treatment-naıve and -experienced patients with genotype 1–6 infection in the allograft without cirrhosis ...
“precision medicine” approach, in which the specific treatment is tailored to a patient's individual metabolomics, ... CLINICS CARE POINTS Alcoholic hepatitis (AH) is a clinical diagnosis, however there are laboratory markers that can ...
In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editors Drs. Andres Cardenas and Thomas Reiberger have created an up-to-date monograph on the complications of cirrhosis.
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int 2016;10:632–9. 51. Kaswala DH, Lai M, Afdhal NH. Fibrosis assessment in nonalcoholic fatty liver ...
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field.
These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection.
CLINIC CARE POINTS The VCE technology is rapidly changing and further advancements are enabling evaluation of various upper and lower GI conditions including but not limited to diagnostic evaluation of upper GI bleeding and colon cancer ...
In electrodesiccation, the electrode tip is in contact with the tissue; with electrofulguration, a 1–2 mm separation between the tip and the tissue produces a spark. Electrodesiccation causes a deeper wound, whereas electrofulguration ...
A randomized, controlled trial demonstrated that asthma management guided by assessment of asthma control leads to improved control of ... cockroach and other insect allergens; and outdoor pollens is common among asthmatic patients.